Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/52008
Title: Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study
Authors: Wägner, Ana María 
Sánchez-Quesada, Jose Luis
Benítez, Sonia
Bancells, Cristina
Ordóñez-Llanos, Jordi
Pérez, Antonio
UNESCO Clasification: 320502 Endocrinología
Keywords: Atorvastatin
Gemfibrozil
Inflammation Markers
C-Reactive Protein
Phospholipase A2
Issue Date: 2011
Publisher: 0168-8227
Journal: Diabetes Research and Clinical Practice 
Abstract: A randomized, crossover study compared the effects of atorvastatin, gemfibrozil and their combination on inflammatory markers in type 2 diabetes. C-reactive protein (CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2), secretory phospholipase A2 (sPLA2), interleukin 8 (IL8), monocyte chemotactic protein 1 (MCP1) and tumor necrosis factor alpha (TNF alpha) were measured. Both lipid-lowering drugs had positive, complementary and additive effects on inflammatory markers, which were closely related to baseline inflammatory status.
URI: http://hdl.handle.net/10553/52008
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2011.03.009
Source: Diabetes Research and Clinical Practice [ISSN 0168-8227], v. 93 (1), p. E25-E28, (Julio 2011)
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

13
checked on May 2, 2021

WEB OF SCIENCETM
Citations

11
checked on Apr 25, 2021

Page view(s)

23
checked on May 2, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.